Patents by Inventor John Christopher Yundt-Pacheco

John Christopher Yundt-Pacheco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11579155
    Abstract: Methods, apparatuses, and systems are disclosed for analyzing quality control (QC) strategies that are applied to testing processes an analyte in order to meet an acceptable level of probability of patient harm that could result from incorrect test results. The measure of patient harm takes into account severity of patient harm, as well as its occurrence. Methods include calculating, based on the parameters of the QC strategies and the test apparatus, an expected number of incorrect final results E(Nuf) due to a test system failure. The value of E(Nuf) can be used as part of a calculation of a predicted level of probability patient harm. The ratio of the acceptable level of probability of patient harm to the predicted level of probability patient harm can determine the adequacy of the QC strategies.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: February 14, 2023
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: John Christopher Yundt-Pacheco, Lakshmi Kuchipudi, Curtis Alan Parvin
  • Publication number: 20190120865
    Abstract: Methods, apparatuses, and systems are disclosed for analyzing quality control (QC) strategies that are applied to testing processes an analyte in order to meet an acceptable level of probability of patient harm that could result from incorrect test results. The measure of patient harm takes into account severity of patient harm, as well as its occurrence. Methods include calculating, based on the parameters of the QC strategies and the test apparatus, an expected number of incorrect final results E(Nuf) due to a test system failure. The value of E(Nuf) can be used as part of a calculation of a predicted level of probability patient harm. The ratio of the acceptable level of probability of patient harm to the predicted level of probability patient harm can determine the adequacy of the QC strategies.
    Type: Application
    Filed: December 20, 2018
    Publication date: April 25, 2019
    Inventors: John Christopher Yundt-Pacheco, Lakshmi Kuchipudi, Curtis Alan Parvin
  • Patent number: 10161947
    Abstract: Methods, apparatuses, and systems are disclosed for analyzing quality control (QC) strategies that are applied to testing processes an analyte in order to meet an acceptable level of probability of patient harm that could result from incorrect test results. The measure of patient harm takes into account severity of patient harm, as well as its occurrence. Methods include calculating, based on the parameters of the QC strategies and the test apparatus, an expected number of incorrect final results E(Nuf) due to a test system failure. The value of E(Nuf) can be used as part of a calculation of a predicted level of probability patient harm. The ratio of the acceptable level of probability of patient harm to the predicted level of probability patient harm can determine the adequacy of the QC strategies.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: December 25, 2018
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: John Christopher Yundt-Pacheco, Lakshmi Kuchipudi, Curtis Alan Parvin
  • Publication number: 20160320420
    Abstract: Methods, apparatuses, and systems are disclosed for analyzing quality control (QC) strategies that are applied to testing processes an analyte in order to meet an acceptable level of probability of patient harm that could result from incorrect test results. The measure of patient harm takes into account severity of patient harm, as well as its occurrence. Methods include calculating, based on the parameters of the QC strategies and the test apparatus, an expected number of incorrect final results E(Nuf) due to a test system failure. The value of E(Nuf) can be used as part of a calculation of a predicted level of probability patient harm. The ratio of the acceptable level of probability of patient harm to the predicted level of probability patient harm can determine the adequacy of the QC strategies.
    Type: Application
    Filed: May 1, 2015
    Publication date: November 3, 2016
    Applicant: Bio-Rad Laboratories, Inc.
    Inventors: John Christopher Yundt-Pacheco, Lakshmi Kuchipudi, Curtis Alan Parvin
  • Patent number: 8712712
    Abstract: A method of establishing statistically valid assay means and ranges for quality control materials, used to qualify medical testing machines, utilizes tests on a new lot of quality control material to establish an assay mean, and uses data from a database of historical test results to establish an assay range. The system may estimate the variability of test results from prior lot data, and then compute the limits of the assay range such that a new test on a new lot of the quality control material will be expected to fall within the range with a specified probability. Because historical data is used to estimate the test variability, the number of new tests required to specify a statistically valid mean and range may be dramatically reduced, as compared with establishing the mean and range based only on tests of the new lot of material.
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: April 29, 2014
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Lakshmi Samyukta Kuchipudi, Curtis Alan Parvin, John Christopher Yundt-Pacheco
  • Publication number: 20120253723
    Abstract: A method of establishing statistically valid assay means and ranges for quality control materials, used to qualify medical testing machines, utilizes tests on a new lot of quality control material to establish an assay mean, and uses data from a database of historical test results to establish an assay range. The system may estimate the variability of test results from prior lot data, and then compute the limits of the assay range such that a new test on a new lot of the quality control material will be expected to fall within the range with a specified probability. Because historical data is used to estimate the test variability, the number of new tests required to specify a statistically valid mean and range may be dramatically reduced, as compared with establishing the mean and range based only on tests of the new lot of material.
    Type: Application
    Filed: March 29, 2011
    Publication date: October 4, 2012
    Applicant: Bio-Rad Laboratories, Inc.
    Inventors: Lakshmi Samyukta Kuchipudi, Curtis Alan Parvin, John Christopher Yundt-Pacheco